billHR7817Event Thursday, March 5, 2026Analyzed

To amend the Patient Protection and Affordable Care Act to ensure that taxpayer funds for health insurance coverage are available only to authorized individuals, and for other purposes.

Neutral
Impact3/10

Summary

HR7817, if enacted, would reduce the pool of individuals eligible for ACA subsidies by restricting eligibility to authorized individuals. This bill is in the early stages of the legislative process, having been referred to two committees on March 5, 2026. Despite the potential for reduced ACA marketplace revenue, health insurer stocks $UNH, $HUM, and $CNC have shown positive 7-day changes.

Key Takeaways

  • 1.HR7817 aims to restrict ACA subsidy eligibility to citizens, nationals, and lawfully present aliens, potentially reducing the ACA marketplace size.
  • 2.The bill is in the early stages of the legislative process, having been referred to two committees, indicating a low probability of immediate enactment.
  • 3.Despite the bill's introduction, $UNH and $CNC have experienced positive 7-day stock performance, suggesting the market is not currently reacting negatively to this legislative development.

Market Implications

The introduction of HR7817 presents a potential long-term headwind for health insurers like UnitedHealth Group ($UNH) and Centene Corporation ($CNC) that participate in the ACA marketplace, as it seeks to reduce the pool of subsidy-eligible individuals. However, the bill's early legislative stage and the positive 7-day stock performance of $UNH (+7.48%) and $CNC (+11.32%) indicate that the market is not currently factoring in a significant impact. Investors should monitor the bill's progression through committees, as further advancement could increase its perceived risk to these companies' ACA-related revenues.

Full Analysis

HR7817, titled the "No Federal Tax Dollars for Illegal Aliens Health Insurance Act of 2026," was introduced in the House of Representatives on March 5, 2026, by Rep. Boebert and 14 cosponsors. The bill has been referred to the Committee on Energy and Commerce and the Committee on Ways and Means. This early stage of the legislative process indicates that the bill has significant steps remaining before it could become law. The bill amends sections 1332(a)(2)(B) and 1332(a)(3) of the Patient Protection and Affordable Care Act. Specifically, it seeks to prohibit the use of federal funds, including pass-through funding to states, to offset the cost of health insurance coverage or provide other benefits for individuals who are not citizens, nationals, or lawfully present aliens in the United States. It also mandates the rescission of any waivers approved under section 1332 that would not have been approved if these amendments were in effect. The bill does not authorize or appropriate any specific funding amount; instead, it aims to restrict the eligibility for existing ACA subsidies, which could reduce the total addressable market for health insurers participating in the ACA marketplace. Structural losers, if this bill were to pass, would be health insurers with significant exposure to the ACA marketplace, as the pool of individuals eligible for subsidies would shrink. Companies like UnitedHealth Group ($UNH), Humana ($HUM), and Centene Corporation ($CNC) operate in this space. However, the bill's impact on these large, diversified insurers would depend on the proportion of their revenue derived from the ACA marketplace and the number of individuals affected. The bill's current status in committee means any direct financial impact is speculative at this time. Despite the introduction of HR7817, health insurer stocks have shown recent positive movement. UnitedHealth Group ($UNH) is currently at $281.36, with a 7-day change of +7.48% and a 30-day change of -2.57%. Centene Corporation ($CNC) is at $35.4, with a 7-day change of +11.32% and a 30-day change of -18.19%. Humana ($HUM) is not provided in the market data. The positive 7-day performance suggests that the market is not currently pricing in a significant negative impact from this early-stage bill. The bill's legislative path involves committee consideration, potential floor votes in the House and Senate, and presidential assent, indicating a lengthy process ahead.

Market Impact Score

3/10
Minimal ImpactModerateMajor Market Event

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

BillStrong LinkBullish

Capping Costs for Consumers Act of 2026

Shared: Health Insurers · Health· Both mention $UNH, $HUM31% match
4/10
BillStrong LinkBearish

Putting Patients First Healthcare Freedom Act

Shared: Centene Corporation · Aca Subsidies · Health· Both mention $UNH, $HUM, $CNC30% match
5/10
BillStrong LinkNeutral

Medical Nutrition Therapy Act of 2026

Shared: Centene Corporation · Change Day· Both mention $UNH, $CNC, $HUM30% match
4/10
BillStrong LinkNeutral

Restoring Patient Protections and Affordability Act of 2025

Shared: Aca Marketplace · Health Insurers · Health Insurance29% match
2/10
BillStrong LinkBullish

Puerto Rico Affordable Care Act of 2025

Shared: Health Insurers · Health Insurance · Aca· Both mention $UNH, $HUM, $CNC28% match
4/10
BillStrong LinkNeutral

To amend the Internal Revenue Code of 1986 to provide a tax credit to health care professionals that provide health care services in qualifying facilities, and for other purposes.

Shared: Unitedhealth Group · Change Day · Health· Both mention $UNH, $HUM26% match
3/10
BillBearish

To amend title XXVII of the Public Health Service Act and the Patient Protection and Affordable Care Act to provide for certain reforms with respect to medical loss ratios and reducing fraudulent enrollment in qualified health plans.

Shared: Health Insurance · Unitedhealth Group · Care Specifically· Both mention $UNH, $HUM24% match
4/10
BillBullish

A bill to ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.

Shared: Health Insurers · Health Insurance · Health· Both mention $HUM23% match
3/10